Showing results 6 to 25 of 71
< previous
next >
Preview | Issue Date | Title | Author(s) |
| 2010 | A new metabotropic glutamate receptor agonist with in vivo anti-allodynic activity | Stanley, N.; Hutchinson, M.; Kvist, T.; Nielsen, B.; Mathiesen, J.; Brauner-Osborne, H.; Avery, T.; Tiekink, E.; Pedersen, D.; Irvine, R.; Abell, A.; Taylor, D. |
| 2002 | A simple method for the preparation of 3-hydroxyiminodehydroquinate, a potent inhibitor of type II dehydroquinase | Le Sann, C.; Abell, C.; Abell, A. |
| 2012 | A study on the diastereoselective synthesis of α-fluorinated β³-amino acids by α-fluorination | Peddie, V.; Abell, A. |
| 2002 | An amino acid N-derivatising group that can be coloured on demand | Abell, A.; Martyn, D.; May, B.; Nabbs, B. |
| 2017 | Azobenzene-containing photoswitchable proteasome inhibitors with selective activity and cellular toxicity | Blanco, B.; Palasis, K.; Adwal, A.; Callen, D.; Abell, A. |
| 2017 | Biosynthetically guided structure-activity relationship studies of Merochlorin A, an antibiotic marine natural product | López-Pérez, B.; Pepper, H.; Ma, R.; Fawcett, B.; Pehere, A.; Wei, Q.; Ji, Z.; Polyak, S.; Dai, H.; Song, F.; Abell, A.; Zhang, L.; George, J. |
| 2006 | Calpain inhibitors and compositions | Abell, A.; Neffe, A.; Stuart, B.; Lee, H.; Morton, J.; Coxon, J.; Nikkel, J.; Robertson, L.; Jones, M.; Muir, M.; Bickerstaffe, R.; Miyamoto, S.; Aitken, S. |
| 2010 | Calpains: Attractive targets for the development of synthetic inhibitors | Pietsch, M.; Chua, K.; Abell, A. |
| 2006 | Compounds and compositions | Abell, A.; Neffe, A.; Stuart, B.; Lee, H.; Morton, J.; Coxon, J.; Nikkel, J.; Duncan, J.; Robertson, L.; Jones, M.; Muir, M.; Klanchantra, M.; Bickerstaffe, R.; McNabb, S.; Aitken, S. |
| 2004 | Conformationally constrained beta-amino acids | Anderson, K.; Gardiner, J.; Abell, A.; Flegel, M.; Fridkin, M.; Gilon, C.; Slaninova, J.; International Peptide Symposium & European Peptide Symposium (3rd & 28th : 2004 : Prague, Czech Republic) |
| 2003 | Cross metathesis of nitrogen-containing systems | Vernall, A.; Abell, A. |
| 2008 | Cross-metathesis and ring-closing metathesis reactions of amino acid-based substrates | Vernall, A.; Ballet, S.; Abell, A. |
| 2004 | Cross-metathesis coupling of sugars and fatty acids to lysine and cysteine | Vernall, A.; Abell, A. |
| 2001 | Design and synthesis of a conformationally restricted trans peptide isostere based on the bioactive conformations of saquinavir and nelfinavir | Edmonds, M.; Abell, A. |
| 2005 | Design and synthesis of aromatic inhibitors of anthranilate synthase | Payne, R.; Bulloch, E.; Abell, A.; Abell, C. |
| 2005 | Developments in the design and synthesis of calpain inhibitors | Neffe, A.; Abell, A. |
| 2010 | Electrochemistry of ferrocenoyl β-peptide monolayers on gold | Brooksby, P.; Anderson, K.; Downard, A.; Abell, A. |
| 2006 | Estrogenicity of pyrethroid insecticide metabolites | McCarthy, A.; Thomson, B.; Shaw, I.; Abell, A. |
| 2016 | Fluorescent IGF-II analogues for FRET-based investigations into the binding of IGF-II to the IGF-1R | Cottam Jones, J.; Harris, P.; Scanlon, D.; Forbes, B.; Brimble, M.; Abell, A. |
| 2010 | Fluorinated β²- and β³-amino acids: synthesis and inhibition of α-chymotrypsin | Peddie, V.; Pietsch, M.; Bromfield, K.; Pike, R.; Duggan, P.; Abell, A. |